Actionable news
0
All posts from Actionable news
Actionable news in RPTP: Raptor Pharmaceutical Corp.,

Raptor Pharma's RP103 fails to beat placebo in pediatric NASH study; shares slump 15% premarket

Raptor Pharmaceuticals (NASDAQ:RPTP) is down 15% premarket on light volume in response to its announcement of additional data from its CyNCh study assessing lead product candidate RP103 for the treatment of children with moderate-to-severe nonalcoholic fatty liver disease (NAFLD). The results will be presented today at The Liver Meeting in San Francisco.

As previously reported on September 14, there was no statistically valid...


More